← Back to headlines
AbbVie's Venetoclax Achieves Milestone in CLL Treatment
AbbVie Inc. (ABBV) has reached a new milestone with its drug Venetoclax in the treatment of Chronic Lymphocytic Leukemia (CLL), marking significant progress in oncology.
1 Jul, 19:53 — 1 Jul, 19:53
Sources
Showing 1 of 1 sources
Related Stories
Uber and Wayve Launch London’s First Autonomous Robotaxi Service
17m ago
Berkshire Hathaway Signals Intent to Increase Stakes in Japanese Trading Houses
38m ago
Rising US-Iran Military Tensions Spark Regional War Fears and Oil Volatility
44m ago
Diversified Energy to Acquire Elliott-Backed Birch Energy for $1.8 Billion
55m ago